Forearm endothelial function and bone mineral loss in postmenopausal women

Atherosclerosis

Volumn 176, Issue 2, 2004, Pages 387-392

  Sanada, Mitsuhiro ^a   Taguchi, Akira ^b   Higashi, Yukihito ^b   Tsuda, Mikio ^a   Kodama, Ichiro ^a   Yoshizumi, Masao ^b   Ohama, Koso ^a  

^a Sanada Hospital   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme; Bone mineral density; Forearm endothelial function; Nitric oxide; Postmenopausal women

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLYCERYL TRINITRATE; NITRATE; NITRITE;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; BONE MINERAL; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPEREMIA; JAPAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; PLETHYSMOGRAPHY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING;

BONE DENSITY; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; DENSITOMETRY, X-RAY; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE;

EID: 5644235491     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.05.021     Document Type: Article

References (36)

1. Browner W.S., Seeley D.G., Vogt T.M., Cummings S.R. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet. 338:1991;355-358
2. Kado D.M., Browner W.S., Blackwell T., Gore R., Cummings S.R. Rate of bone loss is associated with mortality in older women: a prospective study. J. Bone Miner. Res. 15:2000;1974-1980
3. von der Recke P., Hansen M.A., Hassager C. The association between low bone mass at the menopause and cardiovascular disease. Am. J. Med. 106:1999;273-278
4. Pinals R.S., Jabbs J.M. Type-IV hyperlipoproteinaemia and transient osteoporosis. Lancet. 2:1972;929
5. Cappuccio F.P., Meilahn E., Zmuda J.M., Cauley J.A. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 354:1999;971-975
6. Browner W.S., Pressman A.R., Nevitt M.C., Cauley J.A., Cummings S.R. Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke. 24:1993;940-946
7. Cummings S.R., Black D.M., Nevitt M.C., et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 341:1993;72-75
8. Vane J.R., Anggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323:1990;27-36
9. Angard E. Nitric oxide: mediator and medicine. Lancet. 343:1994;1199-1206
10. Vogt M.T., Cauley J.A., Kuller L.H., Nevitt M.C. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J. Bone Miner. Res. 12:1997;283-289
11. Kanis J.A., Melton L.J. III, Christiansen C., Johnston C.C., Khaltaev N. The diagnosis of osteoporosis. J. Bone Miner. Res. 9:1994;1137-1141
12. Panza J.A., Quyyumi A.A., Brush J.E. Jr., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323:1990;22-27
13. Higashi Y., Sasaki S., Kurisu N., et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation. 100:1999;1194-1202
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502
15. 15N nitrate in biological fluids Anal. Biochem. 126:1982;131-138
16. Ohmichi N., Iwai N., Uchida Y., Shichiri G., Nakamura Y., Kinoshita M. Relationship between the response to the angiotensin-converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype. Am. J. Hypertens. 10:1997;951-955
17. van der Klift M., Pols H.A., Hak A.E., Witteman J.C., Hofman A., de Laet C.E. Bone mineral density and the risk of peripheral arterial disease: the Rotterdam Study. Carcif Tissue Int. 70:2002;443-449
18. Barengolts E.I., Berman M., Kukreja S.C., Kouznetsova T., Lin C., Chomka E.V. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Carcif Tissue Int. 62:1998;209-213
19. Ettinger B., Pressman A., Sklarin P., Bauer D.C., Cauley J.A., Cummings S.R. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J. Clin. Endcrinol. Metab. 83:1998;2239-2243
20. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340:1999;1801-1811
21. Felson D.T., Zhang Y., Hannan M.T., Kiel D.P., Wilson P.W., Anderson J.J. The effect of postmenopausal estrogen therapy on bone density in elderly women. N. Engl. J. Med. 329:1993;1141-1146
22. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI, JAMA 1996;276:1389-96.
23. Higashi Y., Sanada M., Sasaki S., et al. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension. 37:2001;651-657
24. Sanada M., Higashi Y., Nakagawa K., et al. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women. J. Clin. Endocrinol. Metab. 87:2002;4634-4641
25. Mastumoto A., Hirata Y., Momomura S., et al. Increased nitric oxide production during exercise. Lancet. 343:1994;849-850
26. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526
27. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012
28. Ralston S.H., Todd D., Helfrich M., Benjamin N., Grabowski P.S. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology. 135:1994;330-336
29. Brown N.J., Blais C. Jr., Gandhi S.K., Adam A. ACE insertion/deletion genotype affects bradykinin metabolism. J. Cardiovasc. Pharmacol. 32:1998;373-377
30. Daemen M.J.A.P., Lombaradi D.M., Bosman F.T., Schwarts S.M. Angiotensin II U induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 68:1991;450-456
31. Parhami F., Morrow A.D., Balucan J., et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17:1997;680-687
32. Parhami F., Garfinkel A., Demer L.L. Role of lipids in osteoporosis. Arterioscler. Thromb. Vasc. Biol. 20:2000;2346-2348
33. Giachelli C.M., Bae N., Almeida M., Denhardt D.T., Alpers C.E., Schwartz S.M. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92:1993;1686-1696
34. Shanahan C.M., Cary N.R., Metcalfe J.C., Weissberg P.L. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 93:1994;2393-2402
35. Burton D.W., Brandt D.W., Deftos L.J. Parathyroid hormone-related protein in the cardiovascular system. Endocrinology. 135:1994;253-261
36. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Kajiyama G., Oshima T. Effect of the angiotensin-converting enzyme Inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. J. Am. Coll. Cardiol. 37:2001;863-870